.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Updates in the Treatment of Diffuse Large B-cell Lymphoma

EP. 1: Dr. Flowers on Long-Term Efficacy With Tafasitamab Plus Lenalidomide in DLBCL

July 19th 2021

Christopher Flowers, MD, discusses the long-term efficacy with tafasitamab-cxix in combination with lenalidomide in diffuse large B-cell lymphoma.

EP. 2: Dr. Xavier on Recent Updates in DLBCL

July 20th 2021

Marin F. Xavier, MD, discusses recent updates in diffuse large B-cell lymphoma based on data from the 2021 ASCO Annual Meeting.

EP. 3: Updates in the Treatment of Diffuse Large B-Cell Lymphoma

September 14th 2021